| Mild | Severe | p | OR | 95% CI | ||||
---|---|---|---|---|---|---|---|---|---|
N | % | N | % | ||||||
Males | rs2285666 | C | 19 | 73.1% | 89 | 74.2% | - | 1 | Reference |
T | 7 | 26.9% | 31 | 25.8% | 0.909 | 0.969 | 0.565–1.662 | ||
rs12329760 | CC | 20 | 76.92% | 74 | 61.67% | - | 1 | Reference | |
CT | 6 | 23.08% | 26 | 21.67% | 0.759 | 1.094 | 0.614–1.950 | ||
TT | 0 | 0% | 20 | 16.67% | 1 | - | - | ||
C | 46 | 88.5% | 174 | 72.5% | - | 1 | Reference | ||
T | 6 | 11.5% | 66 | 27.5% | 0.014 | 1.774 | 1.124–2.801 | ||
Females | rs2285666 | CC | 42 | 64.62% | 57 | 53.77% | - | 1 | Reference |
CT | 13 | 20.00% | 25 | 23.58% | 0.379 | 1.241 | 0.768–2.005 | ||
TT | 10 | 15.38% | 24 | 22.64% | 0.178 | 1.420 | 0.853–2.362 | ||
C | 97 | 74.6% | 139 | 65.6% | - | 1 | Reference | ||
T | 33 | 25.4% | 73 | 34.4% | 0.078 | 1.306 | 0.971–1.758 | ||
rs12329760 | CC | 39 | 60.00% | 98 | 92.45% | - | 1 | Reference | |
CT | 13 | 20.00% | 4 | 3.77% | < 0.001 | 0.275 | 0.138–0.550 | ||
TT | 13 | 20.00% | 4 | 3.77% | < 0.001 | 0.275 | 0.138–0.550 | ||
C | 91 | 70.0% | 200 | 94.3% | - | 1 | Reference | ||
T | 39 | 30.0% | 12 | 5.7% | < 0.001 | 0.298 | 0.198–0.448 |